Edition:
United Kingdom

Julie Steenhuysen

Two health scares at U.S. airports tied to Mecca pilgrims: U.S. officials

08 Sep 2018

CHICAGO Two major health scares at U.S. airports involving inbound flights are related to pilgrims returning from the Hajj, the Muslim pilgrimage to the holy city of Mecca, Saudi Arabia, which ended in late August, U.S. health officials said on Friday.

Eisai/Biogen to advance Alzheimer's drug, provide fresh hope

03 Aug 2018

(In this July 24th story, corrects paragraphs 3 and 16 to clarify that Eisai executive said the trial generated positive, rather than effective, results at lower doses)

Investors turn wary on Biogen/Eisai Alzheimer's drug results

26 Jul 2018

CHICAGO/TOKYO Shares of Eisai Co Ltd plunged as much as 21 percent after the results of its experimental Alzheimer's drug being developed with partner Biogen Inc failed to enthuse investors.

Biogen/Eisai Alzheimer's drug cut cognitive decline by 30 pct -study

25 Jul 2018

CHICAGO, July 25 Biogen Inc and partner Eisai Co Ltd said patients with early-stage Alzheimer's disease treated with their experimental drug BAN2401 experienced 30 percent less cognitive decline than patients who got a placebo in a highly anticipated midstage trial.

Lowering blood pressure cuts risk of memory decline: U.S. study

25 Jul 2018

CHICAGO Aggressively lowering blood pressure significantly reduced the risk of mild cognitive impairment and dementia among hypertension patients in a large government-backed clinical trial, U.S. researchers said on Wednesday.

Focus: Eisai/Biogen to advance Alzheimer's drug, provide fresh hope

24 Jul 2018

Eisai Co Ltd and Biogen Inc will move forward with late-stage clinical trials of their Alzheimer’s disease drug, BAN2401, and are working with regulators to design the next studies and gain expedited review as a breakthrough therapy.

Modified polio vaccine extends lives in U.S. brain cancer study

26 Jun 2018

CHICAGO Some 21 percent of patients with advanced brain cancer treated with a modified polio vaccine were alive after three years, compared with 4 percent of patients with similar tumors who received standard therapies, U.S. researchers said on Tuesday. | Video

Study confirms higher risk of dengue in kids who got Sanofi vaccine

13 Jun 2018

CHICAGO, June 13 An analysis of data on Sanofi's dengue vaccine, which has been given to more than 800,000 school children in the Philippines, confirms it increases the risk of hospitalization and severe dengue in those who had never previously been infected with the mosquito-borne virus.

Rise in U.S. suicides highlights need for new depression drugs

10 Jun 2018

CHICAGO A spike in suicide rates in the United States has cast fresh light on the need for more effective treatments for major depression, with researchers saying it is a tricky development area that has largely been abandoned by big pharmaceutical companies.

Rise in U.S. suicides highlights need for new depression drugs

09 Jun 2018

CHICAGO A spike in suicide rates in the United States has cast fresh light on the need for more effective treatments for major depression, with researchers saying it is a tricky development area that has largely been abandoned by big pharmaceutical companies.

World News